Drug Utilization Research

(53) A Factorial Randomized Trial of Personalized Prescribing Portraits and Evidence Letters to Reduce Long-Term Proton Pump Inhibitor Prescribing in Primary Care

(120) A Multivariate Interrupted Time Series Analysis Assessing the Impacts of Half-Pack Sizes and Increased Access Restrictions on Publicly Subsidised Opioids in Australia

(95) Adherence to Medications and Government Recommendations Among Breast Cancer Women During The COVID-19 Pandemic

(81) A Pharmacoepidemiologic Study of Antibiotics Prescription Patterns in a Tertiary Care Hospital

(B) Impact of the COVID-19 Pandemic on Timeliness of Denosumab Dispensations: An Interrupted Time Series Analysis

(A) Primary Hydroxychloroquine Adherence in Lupus Pregnancy

(C) Trends in Opioid New Users and Subsequent Long-Term Use Among Patients with Rheumatic and Musculoskeletal Diseases Between 2006-2020

(H) Incidence and Prevalence of Prescription Opioid Use During Australian COVID-19 Restrictions

(U) Drug Utilization of Biologic Therapy in Crohn's Disease and Ulcerative Colitis: A Population Based Danish Cohort Study 2015-2020

(102) A Point Prevalence Study of The Use of Antibiotics at Six Tertiary Care Hospitals in The Kathmandu Valley, Nepal

(110) Analysis of Discordantly Identified Criteria in STOPP/START – Problems Underlying Poor Reliability in Practice

(129) ANTIBACDUS-PAN: Antibacterial Utilization Among Adult Patients at Koç University Hospital Before and During COVID-19 Pandemic Within 12-Months Period: A Hospital Pharmacoepidemiology Study

(124) Anticoagulation Use for Hospitalized COVID-19 Patients in the United States: Evolving Patterns from March 2020 to January 2022

(136) Antipsychotic Utilisation Within Primary Care in England from 2010-2020

(134) Antithrombotic Therapy in Atrial Fibrillation Patients with Intracranial Hemorrhage: Retrospective Cohort Study with Administrative Data in Japan

(98) Agreement on Drug Interactions from Two Drug Information System: An Analysis from a Population-Based Survey in The Brazilian Amazon, 2019

(101) Antibiotic Use During Pregnancy: A Swedish Drug Utilization Study from 2006 to 2019

(82) Antibiotic Use for Diarrheal Illness in Patients with a Positive Molecular Gastrointestinal Pathogen Panel Result

(94) An Epidemiological Evaluation of Topical Ophthalmologic Prescriptions Across Age Spectrums Using US Claims Database: 2005 to 2019

(83) Angiotensin Converting Enzyme Inhibitors-Related Adverse Drug Reactions and The Risk of Subsequent Cardiovascular Events and All-Cause Mortality: A Retrospective Cohort Study in The United Kingdom

(61) Antidepressants and Antipsychotics Before and During Pregnancy in the Netherlands

(61) Assessment of Drug-Drug Interactions and Their Associated Risk Factors in Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study

(86) Antihyperglycemic Use in Hemodialysis-Dependent Kidney Failure

(70) Antimicrobial Use in Sweden During The COVID-19 Pandemic: Prescription Filling and Inpatient Care Requisition Patterns

(130) Buprenorphine Utilization Trends Resulting from Multiple State Insurance Reimbursement Policy Changes: An Exploratory Joinpoint Analysis

(64) Antipsychotic Drugs Use in Spain During The COVID-19 Pandemic: A Time Series Analysis Using Autoregressive Integrated Moving Average (ARIMA) and Exponential Smoothing (ETS) Models

(65) Association of Medication Clusters and Labor Market Marginalization in Refugee Youths and Swedish-Born with Common Mental Disorder in Sweden

(101) Changes in Anticoagulant and Antiplatelet Drug Supply at US Hospitals During The COVID-19 Pandemic

(71) Assessments of Potential Adverse Drug Reactions According to a Trigger Tool – A Descriptive Analysis

(135) Characteristics and 1-Year Mortality Outcome of ACS Patients Receiving ACEIs/ARBs: A 10-Year Retrospective Analysis of The Malaysian National Cardiovascular Database Registry

(107) Association of The Swissmedic Safety Alert Regarding Skin Cancer and The Use of Hydrochlorothiazide and Other Antihypertensives in Switzerland

(131) Children with COVID-19: The Real-World Hospital Experience

(101) Barriers and Enablers of Decision-Making Considering Use of Antidepressants – A Mixed-Method Study Among Pregnant and Postpartum Women with a Mental Illness

(85) Changes in Use of Glucose-Lowering Drugs and Physician Responsibility: A Danish Nationwide Study

(50) Characterization and Treatment Patterns of Systemic Lupus Erythematosus Patients - Data from a Large Israeli Health Maintenance Organization

(73) Choice of Initial Treatment with Cholesterol Lowering Drugs in Patients with Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, or Increased Risk of Atherosclerotic Cardiovascular Disease

(74) Community Pharmacists' Knowledge, Attitude, and Practices Towards Antibiotic Use in Bulgaria

(63) Community Pharmacist-Led Interventions and Their Impacts on Patients with Type 2 Diabetes in Low-and Middle-Income Countries: A Scoping Review

(84) Comparing Diabetes Care Outcomes of The Centrally Organized Hoorn Diabetes Care System with Regular Care by General Practitioners in the Netherlands

(58) Current Trends in Continuous Peripheral Nerve Block Use in Total Knee Arthroplasty

(89) COVID-19 Related Drug Utilization Study in Pregnancy – The COVI-Preg Cohort

(103) Differences in The Use of Medications for Treated ADHD Patients Between Children and Adults from Real-World Data in Korea

(117) Development and Validation of a Virtual Reporting Tool for Diabetic Patients' Conventional and Herbal Medicine Use and Treatment Outcomes at a National Referral Hospital in Kenya

(118) Disparities and Changes in PReP Coverage for HIV Prevention Before and During The COVID-19 Pandemic in the U.S.

(90) Disparities in Access to Contraceptives and Abortion Medications Between High Income and Low- and Middle-Income Countries (LMICs) Before and During The COVID-19 Pandemic, 2015-2020

(120) Distribution of Samples of a New Preventive Migraine Drug and Potential Implications for Validity of Pharmacoepidemiology Studies Using Administrative Data

(97) Drug Utilization Pattern Among Patients with Benign Prostatic Hyperplasia in Korea: A Large Cohort Study

(66) Drug Utilization Patterns During Pre-Conception and Pregnancy Period in Women with Systemic Lupus Erythematosus in Korea

(56) Drug Treatment in Older Patients According to Indicators of Potentially Rational Prescribing

(88) Dynamic Pattern of Anti-Epileptic Drug During Pregnancy Among Women with Epilepsy by Using Linking Database in Taiwan

(59) Drug Utilization and Characteristics of COVID-19 Positive Pre- and Postmenopausal Women Diagnosed with Breast Cancer: A Cross-Sectional SCIFI-PEARL Study

(C) The Impact of COVID-19 on Population-Level Drug Utilisation of Alendronate in Five European Databases

(R) Agreement and Correlation Between Different Topical Corticosteroid Potency Classification Systems

(P) In-Hospital Treatment Patterns Among Patients Hospitalized with COVID-19 in the United States

(T) Intended and Unintended Consequences: Changes in Opioid Prescribing Practices Following Two Policies in North Carolina, 2012–2018 – A Controlled Interrupted Time Series Analysis

(N) Respiratory Drugs and Antibiotics Use Before and During COVID-19 in Asthma and COPD Patients: A Quasi-Experimental Study

(U) Statin-Related Adverse Drug Reactions in UK Primary Care Consultations: A Retrospective Cohort Study to Evaluate the Risk of Cardiovascular Events and All-Cause Mortality

(S) Use of Methotrexate in Girls and Women of Childbearing Age and Occurrence of Methotrexate-Exposed Pregnancies in Germany

(Q) Utilization of Antipsychotics for Delirium After Hospitalization for COVID-19 and Other Infections

(O) Variation in The Impact of a Policy to Restrict Coverage of Lidocaine 5% Plasters in Ireland

(X) Age and Sex Differences in Polypharmacy Patterns in New Users of Metformin: A UK-Based Descriptive Study

(V) Polypharmacy and Potential Drug Interactions in the Brazilian Amazon: A Cross-Sectional Population-Based Study, 2019

(Z) Polypharmacy Trends Among US Middle-Aged Adults from 2007 to 2020

(Y) The Impact of Polypharmacy on Antidepressant Discontinuation in Comorbid Depression and Type 2 Diabetes: A UK Primary Care Record Cohort Study

(AF) Evolution of The Treatment Landscape in Patients with Advanced or Metastatic Cancers Following the Approval of Immuno-Oncology Treatments: Analysis of The England National Cancer Registry

(AE) Shifting Treatment Landscape and Overall Survival by PD-L1 Expression Level Among Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC)

(75) Drug Utilization of Anxiolytics and Sedatives Among New Users in Sweden

(133) Drug Utilization of Paliperidone and Risperidone in Adolescent Schizophrenia Patients in China

(102) Drug Utilization Pattern of Non-Steroidal Anti-Inflammatory Drugs Among Pre-End-Stage Renal Disease Patients in Taiwan

(123) Evaluation of Antimicrobial Stewardship Metrics in Medical Intensive Care Unit: A Prospective Interventional Study

(48) Effect of the COVID-19 Pandemic on Medicines Prescription for Children in Portugal

(71) Epidemiology Assessment of Poly-Pharmacy Among Metabolic Syndrome Patients Based on Prescriptions of Iranians Health Insurance Service Data Sets, a Cross Sectional Study

(96) Epilepsy: Trends in Real-World Treatment Patterns in The United States

(77) Facilitators & Barriers of Medication Adherence Amongst the Geriatric: A Developing Country Scenario

(69) Evaluating Brazil's National Administrative Claims Data for Real-World Pharmacoepidemiologic Studies: Trends in Rheumatoid Arthritis Using DATASUS (2010-2020)

(94) Estimating Patients' Knowledge and Behavioral Traits Towards Generic Drugs in Greece

(93) Estimation of COVID-19 Vaccination Uptake by Brand to Inform Global Impact Measurement

(91) Global Extent of The Valsartan Drug Recall and Its Effect on Antihypertensive Drug Use: A Multi-National Study

(99) Group-Based Trajectory Modeling of Medication Refill Patterns of Novel Oral Anticoagulant (NOACs): An Analysis of The Phollow Cohort

(115) Evaluation of Drug-Utilization and Healthcare Facilities Use in Patients with Ulcerative Colitis and Treated with Biologic Therapy Using Data of An Italian Healthcare Administrative Database: Results from MICHELANGELO Study

(62) Immediate Release Fentanyl: Real World Data on Abuse and Dependence in Spain

(114) Impact of National Negotiation and "4+7" Pilot Pooled Procurement on Hepatitis B Antiviral Treatment in Shanghai, China

(118) Factors Associated with Non-Persistence with Statin Treatment in Patients with Peripheral Arterial Disease

(89) Impact of the COVID-19 Controlled Drugs and Substances Act Exemption on Pharmacist Prescribing of Opioids and Benzodiazepines in Ontario: A Cross-Sectional Time-Series Analysis

(104) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in Germany: A Multinational Study with a Common Protocol Led by FDA

(86) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in The U.S., Canada, and Denmark

(87) Impact of Implementing a Guide on Intravenous Fluids to Minimise the Risk of Hospital-Acquired Hyponatraemia in Denmark

(106) Impact of Regulatory Interventions on Ulipristal Acetate (Esmya) Use in Spain: An Interrupted Time-Series Analysis

(97) Impact of Risk Minimisation Measures on The Use of High-Dose Cyproterone Acetate in France

(90) International Trends in Prescription Opioid Sales Among Developed and Developing Countries Prior To, and During The COVID-19 Pandemic: A Cross-Sectional Analysis of 66 Countries

(65) Introducing The Dutch ISPE Student Chapter

(99) Implementation of a Living Lab Intervention in Family Medicine Groups to Improve Medication Use for Seniors with Neurocognitive Disorders

(79) Improving Patient Safety: A Qualitative Study of The Implementation of the 'Know Check Ask' Medication Safety Campaign Among Healthcare Professionals, Patients and Carers

(77) Incidence of Antipsychotic Use Among Community Dwellers With and Without Parkinson's Disease

(55) Initial Choice and Switching of P2Y12 Inhibitors Among Patients with Acute Coronary Syndrome (ACS) After Percutaneous Coronary Intervention (PCI)

(92) Initiation of Antihypertensive Drugs to Patients with Confirmed COVID-19 - a Population-Based Cohort Study in Sweden

(81) Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients with Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020

(93) Melatonin Use Among Children, Adolescents, and Young Adults: A Danish Nationwide Drug Utilization Study

(72) Machine Learning-Based Prediction Models for Outpatient Prescription of Japanese Kampo Formulations: Development and Validation Using a Health Insurance Claims Database

(111) Mortality Consequences of Misuse of Psychoactive Prescription Drugs in Portugal – The MisuMedPT Project

(139) Investigation on Primary Management of Community-Acquired Pneumonia at The Emergency Department in Vietnam

(68) Measuring Access to Medicines for Children: The Robustness of a Child-Specific Indicator

(67) Opioid Utilization Profile in Brazilian Federal Hospitals

(132) Long-Term Trajectories of Prescription Opioid Use in New South Wales, Australia

(60) Optimizing Monitoring Frequency for Clozapine Patients Across the Department of Veterans Affairs Health System

(67) Off-Label Low Dose Amitriptyline for Insomnia Disorder: Patient-Reported Outcomes

(138) Medication Errors Reported to The Danish Patient Safety Database During a Five-Year Period (2014-2018)

(95) Opioid Overdose Risk Prediction in a State Medicaid Program: How Does Predicted Risk Change Over Time?

(74) Persistence and Adherence to Antidiabetic Drugs in Social Health Insurance Participants Attending a Primary Care Clinic in Banjarmasin, Indonesia

(94) Opioid Prescriber Responsibility: A Danish Drug Utilization Study

(107) Medication Use in The Year Before and After a Diagnosis of Cluster B Personality Disorder: Trends and Patterns Between 2002 and 2018 in Quebec, Canada

(73) Persistence and Adherence to Antihypertensive Drugs in The Participants of Social Health Insurance Attending a Primary Care Clinic in Banjarmasin, Indonesia

(112) Medication-Related Problems and Medication Incidents in a Neonatal Intensive Care Unit of a Tertiary Care Hospital

(103) Persistent Opioid Use in Lymphoma Survivors Following Treatment

(122) Personalized Prescribing in Type 2 Diabetes Following The 2015 UK Treatment Guidelines: Description of Non-Insulin Anti-Diabetic Drug (NIAD) Utilization and Polypharmacy Patterns

(100) Morbi-Mortality Consequences of Misuse of Psychoactive Prescription Drugs in Portugal: A Retrospective Observational Study - The MisuMedPT Project

(126) Pharmacoepidemiologic Study on The Use of Psychiatric Medicines in Greece During the Period of 2015-2020

(123) Opioid Prescription Dispensing Patterns Among Patients with Schizophrenia or Bipolar Disorder

(84) Population, Outcome, and Treatment Changes in Secondary Data Early in the COVID-19 Pandemic

(121) Prescribing Patterns of Codeine and Alternatives in Children Across Five EEA Countries Between 2010 and 2017

(49) Post-Myocardial Infarction Guideline-Recommended Therapy Utilization Sankey Diagrams

(100) Prevalence and Determinants of Over- and Undertreatment of Thyroid Dysfunctions in The Rhineland Study

(105) Patient and Health System Factors Associated with Potentially Inappropriate Opioid Use in Non-Cancer Community-Dwelling Older Adults

(121) Patterns of Psychotropic Medicine Use and Initiation in The Year Prior to Death by Suicide: A Population-Based Study

(98) Primary Non-Adherence to Biologics and Immunomodulatory Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis Using Linked EHR and Pharmacy Claims Data

(106) Performance of Three Sets of Criteria for Potentially Inappropriate Prescribing as Diagnostic Tools to Identify Inadequate Drug Treatment

(113) Profile of Antihypertensive Class Drug Usage in Post-Myocardial Infarction Patients in a General Hospital in Banjarmasin During 2016-2020

(112) Profile of Antiplatelet Use in Patients After Myocardial Infarction in a General Hospital in Banjarmasin During 2016-2020

(54) Protocol for Implementing and Evaluating Online Physician Prescribing Portraits: Scalable Low-Cost Audit & Feedback Delivery and Improvement

(110) Psychotropic Medication Use After The COVID-19 Pandemic Transition to Telepsychiatry Services Among the Privately Insured in the United States

(126) Prescribing Patterns for Glucagon-Like Peptide-1 Receptor Agonists Following the Introduction of Semaglutide in Denmark and Norway

(128) Profile of Statin Usage in Post-Myocardial Infarction Patients in a General Hospital in Banjarmasin During 2016-2020

(98) Psychotropic Drug Utilization in An Ambulatory Psychiatric Clinic of a Tertiary Care Hospital

(105) Rising Trends of Opioid Prescription in Brazil, 2014-2019

(113) Real World Prevalence and Use of Immune Checkpoint Inhibitors Among Non-Small Cell Lung Cancer Patients in a Comprehensive Cancer Center

(92) Risk of Drug-Related Upper Gastrointestinal Bleeding in The Total Population of the Netherlands: A Time-Trend Analysis

(79) Risk of Major Adverse Cardiovascular Events in Patients with Rheumatoid Arthritis Using Janus Kinase Inhibitors

(116) Real-World Patterns and Trends of Idarucizumab Use in An Italian Region: A Probabilistic Record-Linkage Approach in The Period 2015-2020

(97) Real-World Prescription Pattern Among Patients with Inflammatory Bowel Disease in Taiwan: A Multi-Institutional Electronic Medical Records Database Analysis

(76) Roll-Out of HIV Pre-Exposure Prophylaxis Use in France: A Nationwide Study from 2016 to 2021

(80) Self-Sufficiency and Pharmaceutical Local Production of Chronic Diseases Medicines in Saudi Arabia: The Case of Type Two Diabetes Medications

(57) Status of The Implementation of National Action Plans—All Countries, 2021

(83) Storage and Disposal of Medicines by Households in Kathmandu Valley, Nepal

(108) Self-Reported Challenges Obtaining Ongoing Prescription Opioids Among Australians with Chronic Non-Cancer Pain

(116) Sex Differences Among Users of NSAIDs and Opioids During COVID-19 Pandemic in Manitoba, Canada

(70) Temporal Trends and Correlates of Early Life Exposure to Acid-Suppressant Therapy

(100) The Association of Patients' Demographics with Glucose-Lowering Drugs Prescription Among Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Observational Studies

(63) The Availability of Essential Medicines for Cardiovascular Diseases in Low- and Middle-Income Countries: A Case Study of Bangladesh

(114) Secular Trends in Utilization of Pharmacologic and Non-Pharmacologic Pain Management Strategies Among Patients with Hip or Knee Osteoarthritis

(117) Susceptibility Reporting and Antibiotic Prescribing for UTIs in The Inpatient Setting: A Nudge Toward Improved Stewardship

(80) Systemic and Biologic Therapy in Atopic Dermatitis

(51) The Use of Metamizol and Other Non-Opioid Analgesics in Switzerland Between 2014 and 2019: A Descriptive Study

(104) The Effects of a Patient-Centered Communication Training on Identifying Drug Related Problems – A Pre and Post Intervention Study in Pharmacy Practice in Denmark and the Netherlands

(90) The Utilisation of Low-Dose Rivaroxaban in Patients with Atherosclerotic Cardiovascular Disease in The United Kingdom and The Netherlands

(106) The Effects of Virtual Care Use on Prescription Drug Claims Among Older Adults with Dementia Before and During COVID-19

(103) Switching Patterns of Mixed Amphetamine Salt Products in the FDA's Sentinel Distributed Database

(91) Time Trends in Antidepressant Use Among Women Aged 45-75 in Germany

(125) The Impact of Polypharmacy on Restarting Antidepressant Treatment in Individuals with Comorbid Depression and Type 2 Diabetes: A UK Primary Care Cohort Study

(69) The Issue of Antibiotic Combinations Prescribing in Outpatients in Syria

(78) Time Trends in The Prescription of Overactive Bladder Agents in England

(52) Titanium Dioxide in Drugs Available on The French Market

(95) The Trends of Racial/Ethnic Disparities in Pain Treatment Among Older Cancer Patients in the US from 2007-2016

(85) Trajectories of Concurrent Opioid and Benzodiazepine Use and Associated Opioid Overdose Risk Among Arizona Medicaid Beneficiaries

(66) Trends in Antibiotic Utilization in Australian Residential Aged Care from 2016-2019: A Case Study of Trends of The Antibiotics Frequently Used to Manage Urinary Tract Infection

(72) Trends and Disparities in Real-World Biomarker Testing and Overall Survival (OS) Among US Patients with Advanced Non-Small Cell Lung Cancer (aNSCLC), 2015–2020

(93) Trends of Antiseizure Medications Utilization in Pregnant People: Population-Level Data from Two Canadian Provinces Over Two Decades

(60) Trends of Thromboprophylaxis Among Newly Diagnosed Multiple Myeloma Patients Initiating Immunomodulatory Drug-Based Regimens, 2010 to 2018

(124) Trends in Dispensing and Utilisation of Tapentadol in Australia

(96) Trends in Insulin Types and Devices Used by Adults with Type 2 Diabetes in the United States, 2016 to 2020

(99) The Initiation of Treatment and One-Year Treatment Non-Persistence Rates in Hypertensive Patients in Lithuania

(87) Understanding Opioid Use Prior to and Immediately Following Cancer Diagnosis Using Group-Based Trajectory Models (GBTM)

(102) The Management of Adult Asthma: An Observational Study into Real-World Prescription Patterns of Inhalation Medication

(62) Use of Prescription Medicines Among Incarcerated Individuals in The United States

(109) Use of Fingolimod and Teriflunomide in Women of Childbearing Age and During Pregnancy in Germany

(119) Use of Psychoactive Medicines in Portugal: A Regional Retrospective Cross-Sectional Study - The MisuMedPT Project

(75) Use of Psychotropic and Antidepressant Medicines in The Brazilian Amazon: Analysis of Two Cross-Sectional Population-Based Studies, 2015 and 2019

(64) Utilisation and Prescribing Patterns of Antipsychotic Medication in The Scottish Primary Care Setting (2010-2020)

(68) Use of Symptomatic Treatments for Alzheimer's Disease Dementia

(89) Utilization Patterns and Predictors of Persistence for Anti-Osteoporosis Treatment Initiators in Denmark: A Population-Based Cohort Study

(115) Utilization of Biologics Used for Plaque Psoriasis: A Descriptive Study

(82) Utilization, User Characteristics, and Adverse Outcomes of Insulin Glargine Originators and Follow-on Drug in Patients with Diabetes in the US

(122) Trends and Characteristics Associated with Nonadherence to Antidepressants Among Breast Cancer Survivors with Depression

(78) Will The Implementation of ISO/CEN Standards for Global Identification of Medicinal Products (IDMP) Make Any Difference for Pharmaco-Epidemiology?

(104) Uptake of Antiviral Treatment of Chronic Hepatitis B: A Panel Data Analysis of 31 Provinces in China (2013-2020)

(109) Use of Analgesics in Denmark: A National Survey

(91) Use of Antibiotics for Urinary Tract Infections Up to and After Nursing Home Admission in Denmark

(108) Use of Pharmacological and Non-Pharmacological Treatments for Chronic Non-Cancer Pain Among People Using Opioids: A Longitudinal Cohort Study

(127) Use of Riluzole Beyond Approved Therapeutic Indications in Three Italian Regions

(92) Using Real-World Data to Examine Treatment Patterns of Patients with Advanced Non-Small Cell Lung Cancer Treated with Systemic Therapies

(137) Utilisation and Prescribing Patterns of Antipsychotics in Primary Care in Wales (2010-2020)

(125) Utilization of Factor Xa Inhibitors and Warfarin in Obese Nonvalvular Atrial Fibrillation (NVAF) Patients: Analysis of University Health Center Electronic Medical Records in The United States (US)

(96) Variations in The Definitions for Prevalence of Chronic Post-Surgical Pain and Persistent Opioid Use After Surgery